The Caseload

Home
Archive
About
New
Top
Discussion
Oscar's S-1: Why It Matters
There's more to this business than $400 million in losses
 • 
Steve Hardgrove
January 2021
Accolade buys 2nd.MD; Point Solutions and Platforms
Making Fee For Service Work Better
 • 
Steve Hardgrove
October 2020
Cash-Pay Potential, Insurance Shortcomings
Putting GoodRx and Sesame into a broader context
 • 
Steve Hardgrove
September 2020
GoodRx's S-1, How PBMs Work, Another Telemedicine integration
This is how you get 40% EBITDA margins
 • 
Steve Hardgrove
July 2020
Blue Cross North Carolina, ACOs, Aledade, Bright Health, Comparing Value Chains
An insurance company makes an offer that independent practices can't refuse
 • 
Steve Hardgrove
June 2020
Sesame, Marketplaces, Price Transparency, and Cutting Out Insurance
A startup builds a marketplace for the uninsured
 • 
Steve Hardgrove
Will the destruction be creative?
Providers vs. Insurers, One Medical and Payment Models, Telemedicine Transcendant
 • 
Steve Hardgrove
March 2020
Coronavirus Look Ahead
What are we in for?
 • 
Steve Hardgrove
The Upside-Down Insurance Incentive
The insurance industry does well when their costs go up?
 • 
Steve Hardgrove
1
February 2020
Radically Different and Fundamentally Lower
EQRx, a biotech startup, launches with bold ambitions to reduce drug prices.  How will they do it?
 • 
Steve Hardgrove
January 2020
Primary Questions
One Medical files an S-1. Will coordinated care find its place in the healthcare value chain?
 • 
Steve Hardgrove
The Disruptors, Part 1: DTC Insurance
Bright Health, Devoted Health, and Oscar have raised a lot of venture money
 • 
Steve Hardgrove
© 2023 Steve Hardgrove
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing